Global Prader-Willi Syndrome Drug Market – Industry Trends and Forecast to 2028

Get Exclusive Sample PDF of this Report Here

Market Analysis and Insights : Global Prader-Willi Syndrome Drug Market

Prader-willi syndrome drug market is expected to gain market growth at a potential rate of 2.75% in the forecast period of 2021 to 2028. Increase in the designations for special drugs from regulatory bodies is the vital factor escalating the market growth.

Prader–Willi syndrome (PWS) is defined as a rare genetic disorder that is characterized by dystonia (weak muscles), feeding problems and poor growth. This condition occurs due to deletion of a part of chromosome 15. Affected patients during early childhood have a constant sense of hunger and they begin to eat excessively and become overweight. Other signs and symptoms include poor development short stature, cognitive impairment and distinctive behavioural characteristics such as stubbornness, temper tantrums and obsessive-compulsive tendencies.

Increase in the research and development initiatives and expenditure will uplift the market growth, also rise in the healthcare expenditures in developing countries and rise in the prevalence of thid disease are some of the crucial factors among others driving the prader-willi syndrome drug market growth. Moreover, rise in the modernization and technological advancements in the healthcare sector will further create new opportunities for the prader-willi syndrome drug market in the forecast period of 2021-2028.

However, low number of approved drugs for this disorder and lack of awareness amongst people about prader-willi syndrome are the major factors among others acting as restraints, and will further challenge the prader-willi syndrome drug market in the forecast period mentioned above.

Prader-willi syndrome drug market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the prader-willi syndrome drug market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Prader-Willi Syndrome Drug Market Scope and Market Size

Prader-willi syndrome drug market is segmented on the basis of type, branded drugs, diagnosis, therapy, treatment, route of administration, distribution channel and end-users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, prader-willi syndrome drug market is segmented into paternal deletion, maternal uniparental disomy (upd), imprinting defect.
• Based on branded drugs, the prader-willi syndrome drug market is segmented into genotropin, omnitrope norditropin, others.
• Based on diagnosis, the prader-willi syndrome drug market is segmented into physical examination, genetic testing, blood test.
• Based on therapy, the prader-willi syndrome drug market is segmented into hormonal therapy, physical therapy and behavioral therapy.
• Based on treatment, the prader-willi syndrome drug market is segmented into medications, dietary treatment, human growth hormone replacement and sex hormone replacement.
• Based on route of administration, the prader-willi syndrome drug market is segmented into oral, subcutaneous, intranasal, others.
• Based on distribution channel, prader-willi syndrome drug market is segmented into direct, online pharmacy, retailers and others.
• Prader-willi syndrome drug market is also segmented on the basis of end-users into hospitals, homecare, specialty clinics and others.

Prader-Willi Syndrome Drug Market Country Level Analysis

Prader-willi syndrome drug market is analysed and market size information is provided by country, type, branded drugs, diagnosis, therapy, treatment, route of administration, distribution channel and end-users as referenced above.

The countries covered in the prader-willi syndrome drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the prader-willi syndrome drug market due to rise in the healthcare affordability in the US, rise in the knowledge and rise in the awareness amongst the people and rise in the technological advancement in this region. Asia-Pacific is the expected region in terms of growth in prader-willi syndrome drug market due to rise in access and quality of healthcare, increase in awareness about target disorder management, and the presence of a wide range of medical solutions in this region.

The country section of the prader-willi syndrome drug market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Prader-willi syndrome drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Prader-Willi Syndrome Drug Market Share Analysis

Prader-willi syndrome drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to prader-willi syndrome drug market.

The major players covered in the prader-willi syndrome drug market report are Pfizer Inc, Novartis AG, Novo Nordisk A/S, Soleno Therapeutics, Inc., Levo Therapeutics, Ferring B.V, Zafgen, Inc., Chong Kun Dang pharmaceutical Corp, Saniona, Millendo Therapeutics, Inc., LG Corp, Insys Therapeutics, Inc., GeneScience Pharmaceuticals Co., Ltd and Rhythm Pharmaceuticals, Inc. among other domestic and global players. Prader-willi syndrome drug market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-46296